Health & Medicine

• Health & Medicine
• Charity News

Cancer Research UK publishes gender and ethnicity pay gap reports

The charity publishes its gender and ethnicity pay gap reports. The charity publishes its gender and ethnicity pay gap reports.

20 January 2022

• Health & Medicine

New breast and lung cancer treatments approved in Scotland

3 new cancer treatments have now been approved by the Scottish Medicines Consortium (SMC) for use on the NHS in Scotland, including 2 breast cancer treatments and 1 for lung cancer. 3 new cancer treatments have now been approved by the Scottish Medicines Consortium (SMC) for use on the NHS in Scotland, including 2 breast cancer treatments and 1 for lung cancer.

19 January 2022

• Health & Medicine

11 top tips for cutting back on alcohol

If you’re one of the many people who want to cut back on drinking this January, but aren’t sure where to start, we've got you covered. If you’re one of the many people who want to cut back on drinking this January, but aren’t sure where to start, we've got you covered.

13 January 2022

• Health & Medicine

New lung cancer treatment combo approved on NHS in England

A new treatment for some people with a type of non small cell lung cancer (NSCLC) will now be routinely available on the NHS in England, following its approval by the National Institute of Health and Care Excellence (NICE). A new treatment for some people with a type of non small cell lung cancer (NSCLC) will now be routinely available on the NHS in England, following its approval by the National Institute of Health and Care Excellence (NICE).

12 January 2022

• Science & Technology
• Health & Medicine

Prising open the trap: Getting to grips with targeted cancer drug resistance

Cancer Research UK-funded scientists are using innovative techniques to understand how resistance to a targeted cancer drug is unfolding. Cancer Research UK-funded scientists are using innovative techniques to understand how resistance to a targeted cancer drug is unfolding.

10 January 2022

• Health & Medicine

Cervical screening in Wales extended to every 5 years: Why the switch?

Wales announced changes to their routine cervical screening programme this week, moving from 3 to 5 years. We look at the science behind the switch. Wales announced changes to their routine cervical screening programme this week, moving from 3 to 5 years. We look at the science behind the switch.

7 January 2022

• Health & Medicine

Immunotherapy approved for some people with advanced melanoma in England

The National Institute for Health and Care Excellence has recommended the use of the immunotherapy drug pembrolizumab (Keytruda) for some adults in England with a type of advanced melanoma skin cancer. The National Institute for Health and Care Excellence has recommended the use of the immunotherapy drug pembrolizumab (Keytruda) for some adults in England with a type of advanced melanoma skin cancer.

21 December 2021

• Health & Medicine

The digital shift: How are remote GP appointments affecting cancer patients?

Covid-19 has changed the way we see the GP. While many have embraced remote appointments, others worry they could lead to missed or delayed cancer diagnoses. Covid-19 has changed the way we see the GP. While many have embraced remote appointments, others worry they could lead to missed or delayed cancer diagnoses.

17 December 2021

• Health & Medicine

Ovarian, bowel and non-Hodgkin's lymphoma treatments approved for NHS use in Scotland

Three new treatment options made available for cancer patients in Scotland. Three new treatment options made available for cancer patients in Scotland.

16 December 2021

• Science & Technology
• Health & Medicine

6 of the biggest good news cancer stories of 2021

From promising new cancer drugs to trialling a cancer blood test, here are some of the top good news stories from 2021. From promising new cancer drugs to trialling a cancer blood test, here are some of the top good news stories from 2021.

15 December 2021

• Health & Medicine

How will new cancer medicines be approved in the future?

In the last decade, many more cancer drugs have become available compared to what we’ve seen previously. This has led to more cancer treatment options, but it has also led to more uncertainty about drugs’ clinical benefit and cost-effectiveness. How can this be addressed? In the last decade, many more cancer drugs have become available compared to what we’ve seen previously. This has led to more cancer treatment options, but it has also led to more uncertainty about drugs’ clinical benefit and cost-effectiveness. How can this be addressed?

2 December 2021